Did Thomas Tuberville sell Bristol Myers Squibb stock?
Republican · U.S. Senate · Alabama
Latest filing May 15, 2025
Yes. Thomas Tuberville disclosed 3 sales of Bristol Myers Squibb (BMY) stock between Nov 16, 2023 and Apr 15, 2025, in STOCK Act reports. Added together, the disclosed ranges come to $3K-$45K. The reports also list 2 option trades.
Did Thomas Tuberville sell Bristol Myers Squibb stock?
Yes. Thomas Tuberville disclosed 3 sales of Bristol Myers Squibb (BMY) stock between Nov 16, 2023 and Apr 15, 2025, in STOCK Act reports. Added together, the disclosed ranges come to $3K-$45K. The reports also list 2 option trades.
How big were Thomas Tuberville's Bristol Myers Squibb trades?
STOCK Act reports give a range for each trade, such as $1K-$15K, never an exact amount. Added together, the disclosed ranges come to $3K-$45K.
Did Thomas Tuberville make these Bristol Myers Squibb trades personally?
Not always. The STOCK Act requires members to report trades by themselves, a spouse and dependent children. The owner column of each linked filing says whose trade it was.
Does Thomas Tuberville still own Bristol Myers Squibb stock?
This page lists reported trades, not holdings. A purchase can have been sold since, and the filings shown do not say what is held today.
When did Thomas Tuberville report these trades?
The latest filing is dated May 15, 2025. The STOCK Act gives members of Congress 45 days to report a trade, so a filing can trail the trade by weeks. Every row shows both dates.
Where does this data come from?
From periodic transaction reports filed under the STOCK Act with the Secretary of the Senate. Every trade links to the original filing.
Loading